Suxibuzone-d9

CAS: 27470-51-5

Ref. TR-S880002

Produktinformation

• Name: Suxibuzone-d9
• Synonyme: Butanedioic Acid 1-[(4-Butyl-3,5-dioxo-1,2-diphenyl-4-pyrazolidinyl)methyl] Ester-d9, Butanedioic Acid Mono[(4-butyl-3,5-dioxo-1,2-diphenyl-4-pyrazolidinyl)methyl] Ester-d9, Succinic acid, Monoester with 4-Butyl-4-(hydroxymethyl)-1,2-diphenyl-3,5-pyrazolidinedione-d9, 4-butyl-4-(hydroxymethyl)-1,2-diphenyl-3,5-pyrazolidinedione Hydrogen Succinate-d9, 4-Hydroxymethylbutazolidine Hemisuccinate-d9, AE 17-d9, Calibene-d9, Danilon-d9, Flogos-d9, Solurol-d9, Suxibutazone-d9, 3,5-Pyrazolidinedione, 4-butyl-4-(hydroxymethyl)-1,2-diphenyl-, hydrogen succinate (ester), 4-Hydroxymethylbutazolidine hemisuccinate, 4-[(4-Butyl-3,5-Dioxo-1,2-Diphenylpyrazolidin-4-Yl)Methoxy]-4-Oxobutanoic Acid, Ae 17, Butanedioic acid, 1-[(4-butyl-3,5-dioxo-1,2-diphenyl-4-pyrazolidinyl)methyl] ester, Butanedioic acid, mono[(4-butyl-3,5-dioxo-1,2-diphenyl-4-pyrazolidinyl)methyl] ester, Calibene, Danilon, Flogos, Solurol, Succinic acid, monoester with 4-butyl-4-(hydroxymethyl)-1,2-diphenyl-3,5-pyrazolidinedione, Suxibutazone

Beschreibung

Applications Suxibuzone-d9 is labelled Suxibuzone (S880000) which is a prodrug of the non steroidal anti inflammatory drug phenylbutazone. It is a drug used for joint and muscular pain.
References Monreal, L., et al.: res. Vet. Sci., 76, 145 (2004); Mizushima, Y., et al.: Pharm., 25, 39 (1982); Yasuda, Y., et al.: J. Pharm. Sci., 71, 565 (1982)

• Marke: TRC

Chemische Eigenschaften

• Molekulargewicht: 447.53
• Formel: C₂₄H₁₇D₉N₂O₆
• Farbe/Form: Neat
• InChl: InChI=1S/C24H26N2O6/c1-2-3-16-24(17-32-21(29)15-14-20(27)28)22(30)25(18-10-6-4-7-11-18)26(23(24)31)19-12-8-5-9-13-19/h4-13H,2-3,14-17H2,1H3,(H,27,28)/i1D3,2D2,3D2,16D2
• InChI Key: InChIKey=ONWXNHPOAGOMTG-ZHCFYZTJSA-N
• SMILES: [2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C1(COC(=O)CCC(=O)O)C(=O)N(c2ccccc2)N(c2ccccc2)C1=O